References
Maron BJ (2002) Hypertrophic cardiomyopathy: a systematic review. JAMA 287:1308–1320
Maron BJ, Spirito P, Shen WK et al (2007) Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA 298:405–412
Maron BJ, McKenna WJ, Danielson GK et al (2003) American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. J Am Coll Cardiol 42:1687–1713
Eriksson MJ, Sonnenberg B, Woo A et al (2002) Long-term outcome in patients with apical hypertrophic cardiomyopathy. J Am Coll Cardiol 39:638–645
Nasermoaddeli A, Miura K, Matsumori A et al (2007) Prognosis and prognostic factors in patients with hypertrophic cardiomyopathy in Japan: results from a nationwide study. Heart 93:711–715
Lee CH, Liu PY, Lin LJ et al (2006) Clinical features and outcome of patients with apical hypertrophic cardiomyopathy in Taiwan. Cardiology 106:29–35
Kitaoka H, Doi Y, Casey SA et al (2003) Comparison of prevalence of apical hypertrophic cardiomyopathy in Japan and the United States. Am J Cardiol 92:1183–1186
Choi EY, Rim SJ, Ha JW et al (2008) Phenotypic spectrum and clinical characteristics of apical hypertrophic cardiomyopathy: multicenter echo-Doppler study. Cardiology 110:53–61
Duygu H, Zoghi M, Nalbantgil S et al (2008) Apical hypertrophic cardiomyopathy might lead to misdiagnosis of ischaemic heart disease. Int J Cardiovasc Imaging. doi:10.1007/s10554-008-9311-7
McKenna WJ, Behr ER (2002) Hypertrophic cardiomyopathy: management, risk stratification, and prevention of sudden death. Heart 87:169–176
Rickers C, Wilke NM, Jerosch-Herold M et al (2005) Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation 112:855–861
Moon JC, Fisher NG, McKenna WJ et al (2004) Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography. Heart 90:645–649
Pons-Lladó G, Carreras F, Borrás X et al (1997) Comparison of morphologic assessment of hypertrophic cardiomyopathy by magnetic resonance versus echocardiographic imaging. Am J Cardiol 79:1651–1656
Zipes DP, Camm AJ, Borggrefe M et al (2006) American College of Cardiology/American Heart Association/European Society of Cardiology guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. J Am Coll Cardiol 48(5):e247–e346
Moon JC, McKenna WJ, McCrohon JA et al (2003) Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 41:1561–1567
Adabag AS, Maron BJ, Appelbaum E et al (2008) Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol 51:1369–1374
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Alpendurada, F., Prasad, S.K. The missing spade: apical hypertrophic cardiomyopathy investigation. Int J Cardiovasc Imaging 24, 687–689 (2008). https://doi.org/10.1007/s10554-008-9335-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10554-008-9335-z